SCYGR9
Small cysteine and glycine repeat-containing protein 9
Also known as: SCGR9_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for SCYGR9 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
92 residues, UniProt reviewed canonical sequence.
>P0DSO2|SCYGR9
1 MGCCGCGSCG CSGGCGGGCG GGCGGGCGSC TTCRCYRVGC CSSCCPCCRG CCGGCCSTPV
61 ICCCRRTCSS CGCGCGKGCC QQKSCCQKQC CCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SCYGR9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
OntologyGO
Cellular components
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SCYGR9 as an antibody target. Whether an autoantibody or antibody against SCYGR9 could matter depends on whether native SCYGR9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SCYGR9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SCYGR9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...